TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32829703

Group type: EXPERIMENTAL
Intervention: Mumps-specific IgG antibody testing using Enzygnost anti-parotitis IgG enzyme immunoassay
Number of subjects: 2729

Group type: COMPARATOR
Intervention: Comparison with previous national serosurveys (2007-2008 and 1997-1998)
Number of subjects: 2729

Group type: EXPERIMENTAL
Intervention: Age group analysis
Number of subjects: 2729
Study: 35715625

Group type: EXPERIMENTAL
Intervention: Intranasal insulin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34783839

Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 2572

Group type: COMPARATOR
Intervention: Background medication-based individualized comparator (enalapril, valsartan, or placebo)
Number of subjects: 2572

Group type: COMPARATOR
Intervention: Background medication-based individualized comparator
Number of subjects: 2572
Study: 32865762

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 0
Study: 33395500

Group type: EXPERIMENTAL
Intervention: Health coaching intervention
Number of subjects: 108

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 108
Study: 35667389

Group type: EXPERIMENTAL
Intervention: RFA followed by SEMS insertion (n=42)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Self‐expandable metal stent only (SEMS‐only, n=44)
Number of subjects: 86
Study: 36259713

Group type: EXPERIMENTAL
Intervention: RDN+AF ablation
Number of subjects: 61

Group type: COMPARATOR
Intervention: AF-only ablation
Number of subjects: 61
Study: 33044196

Group type: EXPERIMENTAL
Intervention: Active antidepressants (fluoxetine, duloxetine, paroxetine, sertraline)
Number of subjects: 4717

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4717
Study: 35354342

Group type: EXPERIMENTAL
Intervention: Drug-eluting balloon (DEB)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Plain old balloon angioplasty (POBA)
Number of subjects: 42
Study: 34863138

Group type: EXPERIMENTAL
Intervention: Improved biomass cookstoves
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (traditional stoves)
Number of subjects: 200
Study: 35638415

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Relaxation Training (RT)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 153
Study: 33938432

Group type: EXPERIMENTAL
Intervention: Combination serum containing galactomyces ferment filtrate (GFF), dexpanthenol, and Centella asiatica, administered as three drops twice daily for 8 weeks.
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combination serum containing GFF, dexpanthenol, and C. asiatica
Number of subjects: 51
Study: 32878759

Group type: EXPERIMENTAL
Intervention: Combined physical and psychological intervention (BOOST programme)
Number of subjects: 0
Study: 35325703

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: ICECAP-O
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L and ICECAP-O
Number of subjects: 715
Study: 33878196

Group type: EXPERIMENTAL
Intervention: Erector spinae block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 60
Study: 36115638

Group type: EXPERIMENTAL
Intervention: Emotion Regulation Therapy for Caregivers (ERT-C)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Caregivers (CBT-C)
Number of subjects: 200
Study: 33931185

Group type: EXPERIMENTAL
Intervention: 10 sessions of rTMS
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 20 sessions of rTMS
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both rTMS protocols
Number of subjects: 90
Study: 34614146

Group type: EXPERIMENTAL
Intervention: POD24 (progression of disease within 24 months)
Number of subjects: 5225

Group type: EXPERIMENTAL
Intervention: Clinical factors predicting POD24
Number of subjects: 5225
Study: 34535197

Group type: EXPERIMENTAL
Intervention: TPX-100 (200 mg)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 32571432

Group type: EXPERIMENTAL
Intervention: Basic promotion of the StopBlues program by local authorities
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Intensified promotion of the StopBlues program in a general practitioner's waiting room
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group with no initial promotion, followed by sustained promotion after 12 months
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: StopBlues program usage
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Help-seeking behaviors
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Psychological distress
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness and budgetary impact
Number of subjects: 34
Study: 36001764

Group type: EXPERIMENTAL
Intervention: Increased daytime physical activity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher behavioral and psychological symptoms of dementia (BPSD)
Number of subjects: 0
Study: 33268017

Group type: EXPERIMENTAL
Intervention: MCT oil dietary supplementation
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control oil dietary supplementation
Number of subjects: 29
Study: 34414904

Group type: EXPERIMENTAL
Intervention: Resveratrol 500 mg a day with meloxicam 15 mg a day for 90 days
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo with meloxicam 15 mg a day for 90 days
Number of subjects: 110
Study: 36312793

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 32245343

Group type: EXPERIMENTAL
Intervention: Median Urinary Iodine Concentration (MUI) measured in 1997, 1999, 2011, 2014, and 2017 with values of 228 µg/L, 214 µg/L, 1826 µg/L, 171 µg/L, and 183 µg/L respectively.
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Median Thyroid Volume (MTvol) measured in 1997, 1999, 2011, 2014, and 2017 with values of 2.9 mL, 1.2 mL, 2.4 mL, 1.0 mL, and 1.8 mL, and 2.8 mL respectively.
Number of subjects: 1200
Study: 35872963

Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 126

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 126
Study: 33618027

Group type: EXPERIMENTAL
Intervention: All colonoscopies (irrespective of indication)
Number of subjects: 2628

Group type: COMPARATOR
Intervention: Screening exams
Number of subjects: 2628

Group type: EXPERIMENTAL
Intervention: Surveillance exams
Number of subjects: 2628

Group type: EXPERIMENTAL
Intervention: Diagnostic exams
Number of subjects: 2628
Study: 32544269

Group type: EXPERIMENTAL
Intervention: Laser group (LG, InGaAlP, 660 nm, 86.7 mW, 2 J/cm2)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (CG, simulated procedure without light emission)
Number of subjects: 54
Study: 35751161

Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV) at a daily dose of 600 mg orally in combination with other antiretrovirals (ARVs)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: CYP2B6 516G>T genotype (wild-type GG, heterozygote GT, polymorphic homozygote TT)
Number of subjects: 96
Study: 34567245

Group type: EXPERIMENTAL
Intervention: Secondary cytoreduction and HIPEC (Cisplatin 75 mg/m2 43°C over 60 minutes)
Number of subjects: 15
Study: 33189262

Group type: EXPERIMENTAL
Intervention: Mixed buffer powder (MBP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Basic bicarbonate electrolyte powder (BBP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Liquid electrolyte (HAL)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All treatments (BBP, MBP, HAL)
Number of subjects: 80
Study: 33942292

Group type: EXPERIMENTAL
Intervention: R-CHOP plus ibrutinib
Number of subjects: 746

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 746
Study: 32947569

Group type: EXPERIMENTAL
Intervention: Lower-load resistance training (LLRT; loads <50% of 1 repetition maximum [1RM])
Number of subjects: 29

Group type: COMPARATOR
Intervention: Higher-load resistance training (HLRT; loads >70% of 1 repetition maximum [1RM])
Number of subjects: 29
Study: 33423544

Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 13

Group type: COMPARATOR
Intervention: SHAM
Number of subjects: 13
Study: 36090567

Group type: EXPERIMENTAL
Intervention: 80:40 group (80 mg/kg/day ARA and 40 mg/kg/day DHA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 120:60 group (120 mg/kg/day ARA and 60 mg/kg/day DHA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 120:60 group
Number of subjects: 18

Group type: COMPARATOR
Intervention: 80:40 group
Number of subjects: 18
Study: 35930838

Group type: EXPERIMENTAL
Intervention: Microbially diverse sand
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo sand
Number of subjects: 26
Study: 34609956

Group type: EXPERIMENTAL
Intervention: Asynchronous Video Observed Treatment (aVOT)
Number of subjects: 647

Group type: COMPARATOR
Intervention: Directly Observed Treatment (DOT)
Number of subjects: 647
Study: 32828623

Group type: EXPERIMENTAL
Intervention: Right ventricular apical (RVA) pacing
Number of subjects: 284

Group type: COMPARATOR
Intervention: Non-RVA pacing
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: RVA pacing
Number of subjects: 284
Study: 36385690

Group type: EXPERIMENTAL
Intervention: Nitrate containing beetroot juice (400 mg daily)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (0 mg daily)
Number of subjects: 49
Study: 33305862

Group type: EXPERIMENTAL
Intervention: High-frequency (10 Hz) rTMS
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst stimulation (iTBS)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 388
Study: 624995555

Group type: EXPERIMENTAL
Intervention: Nocturnal CPAP (8-10 cm H2O)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sham CPAP (<2 cm H2O)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 55
Study: 33974126

Group type: EXPERIMENTAL
Intervention: 30 bouts of 4 s maximal cycling sprints with 15 s recovery
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 30 bouts of 4 s maximal cycling sprints with 30 s recovery
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 30 bouts of 4 s maximal cycling sprints with 45 s recovery
Number of subjects: 16
Study: 34382932

Group type: EXPERIMENTAL
Intervention: Intervention group receiving brief support for self-management of weight during child immunisation visits.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual-care group receiving a healthy lifestyle leaflet.
Number of subjects: 28
Study: 32332423

Group type: EXPERIMENTAL
Intervention: Group A: Q‐tip touch test, speculum examination, then bimanual examination
Number of subjects: 200

Group type: COMPARATOR
Intervention: Group B: Q‐tip touch test, bimanual examination, then speculum examination
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Group A and Group B (combined)
Number of subjects: 200
Study: 35948456

Group type: EXPERIMENTAL
Intervention: CEUS + 360°-TRUS
Number of subjects: 156

Group type: COMPARATOR
Intervention: TRUS
Number of subjects: 156
Study: 32747329

Group type: EXPERIMENTAL
Intervention: Gamified e-learning module
Number of subjects: 291

Group type: COMPARATOR
Intervention: Control group (guidelines access before e-learning module)
Number of subjects: 291
Study: 35025154

Group type: EXPERIMENTAL
Intervention: WANG Ju-yi's meridian diagnosis method combined with Bobath rehabilitation training
Number of subjects: 106

Group type: COMPARATOR
Intervention: Bobath rehabilitation training alone
Number of subjects: 106
Study: 32042081

Group type: EXPERIMENTAL
Intervention: CLL1-PM (prognostic model)
Number of subjects: 539
Study: 32293830

Group type: EXPERIMENTAL
Intervention: Tetris and therapy (EMDR)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (therapy only - EMDR)
Number of subjects: 40
Study: 35731497

Group type: EXPERIMENTAL
Intervention: Self-compassion letter writing condition
Number of subjects: 53

Group type: COMPARATOR
Intervention: Neutral writing control
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Higher trait self-compassion
Number of subjects: 53
Study: 34370275

Group type: EXPERIMENTAL
Intervention: Cladribine tablets 3.5 mg/kg (CP3.5 group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cladribine tablets 3.5 mg/kg (CC7 group)
Number of subjects: 0
Study: 32525946

Group type: EXPERIMENTAL
Intervention: Jumping exercises on a short-arm centrifuge at constant +1Gz
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Jumping exercises on a short-arm centrifuge at variable Gz (+0.5, +0.75, +1, +1.25, +1.5 Gz)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Vertical jumps (control intervention)
Number of subjects: 15
Study: 35293087

Group type: EXPERIMENTAL
Intervention: Dronedarone 400 mg twice daily
Number of subjects: 4628

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4628
Study: 33795780

Group type: EXPERIMENTAL
Intervention: Repaired under tension (Group A, n=38)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Repaired without tension (Group B, n=52)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study: 36449490

Group type: EXPERIMENTAL
Intervention: Proposed reference range and sample size procedures for parallel-group studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Computer programs for efficient calculation and exact analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real data example regarding tablet absorption rate and extent
Number of subjects: 0
Study: 32926850

Group type: EXPERIMENTAL
Intervention: 15% dextrose injection (D15W)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (normal saline injection)
Number of subjects: 50
Study: 32406581

Group type: EXPERIMENTAL
Intervention: Health Facility Visit + Soapy Water Arm
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Health Facility Visit + Handwashing Station Arm
Number of subjects: 404
Study: 35803981

Group type: EXPERIMENTAL
Intervention: Bayesian approach for modeling interaction of coffee genotypes with the environment
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Z21 genotype
Number of subjects: 43
Study: 32895080

Group type: EXPERIMENTAL
Intervention: EAT‐26 scale
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: Higher EAT‐26 scores
Number of subjects: 811
Study: 36125874

Group type: EXPERIMENTAL
Intervention: Group F (ferrule preparation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Group B (butt joint porcelain margin)
Number of subjects: 20
Study: 34814700

Group type: EXPERIMENTAL
Intervention: Anterior-lateral electrode position
Number of subjects: 468

Group type: COMPARATOR
Intervention: Anterior-posterior electrode position
Number of subjects: 468
Study: 33214480

Group type: EXPERIMENTAL
Intervention: Nissen fundoplication
Number of subjects: 107

Group type: COMPARATOR
Intervention: Anterior 180-degree partial fundoplication
Number of subjects: 107
Study: 33154023

Group type: EXPERIMENTAL
Intervention: Oral supplementation with 16,000 IU of calcifediol per week
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo added to usual asthma treatment
Number of subjects: 112
Study: 32043561

Group type: EXPERIMENTAL
Intervention: Occupational therapy (OT) behavioral intervention
Number of subjects: 101

Group type: COMPARATOR
Intervention: Diabetes self-management education
Number of subjects: 101
Study: 34342936

Group type: EXPERIMENTAL
Intervention: Stenting (10 subjects, 10% of total), along with medical management
Number of subjects: 110

Group type: COMPARATOR
Intervention: Medical management only
Number of subjects: 110
Study: 33038438

Group type: EXPERIMENTAL
Intervention: Mechanical CPR (Jolfe AB/Stryker, Lund, Sweden)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Manual CPR
Number of subjects: 127
Study: 34998991

Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Bugs) in unblinded tests
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Boolomo) in unblinded tests
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Bugs) in single-blinded tests
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Boolomo) in single-blinded tests
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Bugs) in double-blinded studies
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Boolomo) in double-blinded studies
Number of subjects: 216
Study: 35807854

Group type: EXPERIMENTAL
Intervention: 10 g of whey protein microgel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 250 mg mulberry leaf extract with a complete 510 kcal meal
Number of subjects: 0
Study: 32354736

Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 0
Study: 33877019

Group type: EXPERIMENTAL
Intervention: Intravenous urokinase
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Antiplatelet agents
Number of subjects: 1002
Study: 33574437

Group type: EXPERIMENTAL
Intervention: Midazolam intravenous sedation
Number of subjects: 20
Study: 35959710

Group type: EXPERIMENTAL
Intervention: Modified video-feedback intervention delivered in-home by trained mental health professionals over a period of 4-6 months.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 30
Study: 33856417

Group type: EXPERIMENTAL
Intervention: Multiparametric Magnetic Resonance Imaging–Targeted Biopsy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systematic Transrectal Ultrasonography Biopsy
Number of subjects: 0
Study: 32527120

Group type: EXPERIMENTAL
Intervention: Medical Comics (MCs)
Number of subjects: 506
Study: 36264198

Group type: EXPERIMENTAL
Intervention: Virtual child disease management programme for 8 weeks
Number of subjects: 80
Study: 32959346

Group type: EXPERIMENTAL
Intervention: Severe traumatic injury
Number of subjects: 8727

Group type: EXPERIMENTAL
Intervention: Less severe traumatic injury
Number of subjects: 8727

Group type: COMPARATOR
Intervention: No documented injury
Number of subjects: 8727
Study: 32868588

Group type: EXPERIMENTAL
Intervention: Weighted blanket
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nonweighted blanket
Number of subjects: 16
Study: 35171197

Group type: EXPERIMENTAL
Intervention: Transcutaneous magnetic stimulation (TcMS) targeting the left stellate ganglion (n=14)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham stimulation (n=12)
Number of subjects: 26
Study: 33962125

Group type: EXPERIMENTAL
Intervention: Basic measurement (BM) with calibration of 20 mm/mV and a sweep speed of 50 mm/s, enhancement 10×
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: High precision measurement (HPM) with a sweep speed of 150 mm/s, enhancement 80-160×
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: High precision measurement (HPM) in cases with P-DCS < 80 ms
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Basic measurement (BM) and High precision measurement (HPM)
Number of subjects: 153
Study: 32085836

Group type: EXPERIMENTAL
Intervention: 150 mg S44819 twice a day
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: 300 mg S44819 twice a day
Number of subjects: 585

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 585
Study: 36174812

Group type: EXPERIMENTAL
Intervention: Ogawa® passive sampler with acid‐coated pads
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Exposed acid‐coated pads without casing
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acid‐coated pads with protective casing
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard boric acid solution
Number of subjects: 40
Study: 32857445

Group type: EXPERIMENTAL
Intervention: Varenicline directly observed therapy (DOT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Varenicline self-administered therapy (SAT)
Number of subjects: 100
Study: 35465733

Group type: EXPERIMENTAL
Intervention: alpelisib + trastuzumab (HR-negative cohort)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: alpelisib + trastuzumab + fulvestrant (HR-positive cohort)
Number of subjects: 300

Group type: COMPARATOR
Intervention: trastuzumab + chemotherapy (eribuline, capecitabine, or vinorelbine)
Number of subjects: 300
Study: 35788754

Group type: EXPERIMENTAL
Intervention: AI-based ultra-low-dose contrast medium (ULDCM)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Low-dose contrast medium (LDCM)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Ultra-low-dose contrast medium (ULDCM)
Number of subjects: 150
Study: 34865332

Group type: EXPERIMENTAL
Intervention: Penetrating technique of scalp acupuncture + music education rehabilitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Music education rehabilitation
Number of subjects: 60
Study: 32212508

Group type: EXPERIMENTAL
Intervention: Acupoint injection of Shuxuetong (SXT)
Number of subjects: 78
Study: 32108724

Group type: EXPERIMENTAL
Intervention: Individualized volume (IND)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standardized volume (N-IND)
Number of subjects: 16
Study: 32372217

Group type: EXPERIMENTAL
Intervention: 1 hour exercise session at 6:30 pm (E6:30)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1 hour exercise session at 8:30 pm (E8:30)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control session (CTL)
Number of subjects: 16
Study: 35045869

Group type: EXPERIMENTAL
Intervention: Meclofenamate (MFA) combined with standard dose Temozolomide (TMZ)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard dose Temozolomide (TMZ)
Number of subjects: 42
Study: 34661548

Group type: COMPARATOR
Intervention: Tablet PC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Smart Glasses
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tablet PC and Smart Glasses
Number of subjects: 40
Study: 33367543

Group type: EXPERIMENTAL
Intervention: Higher γ' fibrinogen levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher total fibrinogen levels
Number of subjects: 0
Study: 35387701

Group type: EXPERIMENTAL
Intervention: 3M 9320A+
Number of subjects: 1000

Group type: COMPARATOR
Intervention: 3M 1870+
Number of subjects: 1000
Study: 32703613

Group type: EXPERIMENTAL
Intervention: 30 minutes of myofascial induction session
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo control group (unplugged pulsed 30 minutes of shortwave therapy)
Number of subjects: 21